Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Dolomite Introduces Microfluidic System
Friday, February 28, 2014
Dolomite’s Telos system for high throughput droplet microfluidics.

The Future of Photochemistry with Vapourtec’s UV-150
Friday, February 28, 2014
Designed to complement Company’s existing R-Series and E-Series systems.

Precise Low Temperature Control Improves Reaction Reproducibility
Friday, February 28, 2014
DrySyn SnowStorm system from Asynt perform low temperature reactions.

Tornado Hits Chinese Labs
Saturday, February 22, 2014
Offers controlled parallel heating and mechanical stirring.

Temperature Control Hoses with Improved Flow Characteristics
Friday, February 21, 2014
Hoses with smooth internal wall for shorter heating and cooling times.

Freeman Technology Highlights the FT4 Powder Rheometer® at Interphex 2014
Wednesday, February 19, 2014
Specialists will provide practical advice on all aspects of powder characterization.

Milestone for Vapourtec R-Series Flow Chemistry System
Wednesday, February 19, 2014
Vapourtec R-Series sales top 200.

New Vacuum Technology for the Analytical Market and R&D Requirements
Tuesday, February 18, 2014
The new dimension in turbo molecular pump engineering - TURBOVAC i.

Sciformix to Present Novel Best Practices in Labeling Management
Friday, February 14, 2014
Presentation will highlight how SciLabel Pro employs technology, people and LEAN processes to transform global labeling management, increasing accuracy and efficiency.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 917
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv